Skip to main content
eScholarship
Open Access Publications from the University of California

UC San Diego

UC San Diego Electronic Theses and Dissertations bannerUC San Diego

Synthetic Lethal Interaction Between BRCA1 and FEN1 in Ovarian Cancer Cells

  • Author(s): Huang, Yueyang
  • Advisor(s): Wang, Jean Y.J.
  • et al.
No data is associated with this publication.
Abstract

The concept of synthetic lethality (SL) can be applied to selectively kill cancer cells by targeting SL-partners of a cancer-specific mutation. The SL-interaction between homologous recombination (HR) and the flap endonuclease was first established in yeast, and recently confirmed in human cells by showing that HR-deficient (BRCA1-deficient) cell lines are more sensitive to flap endonuclease 1 (FEN1)-inhibitors than BRCA1-proficient cell lines. To further establish that BRCA1-loss is sufficient to cause FEN1-inhibitor sensitivity in ovarian cancer, I used the CRISPR/Cas9 gene-editing methods to correct the BRCA1 mutation in the FEN1-inhibitor sensitive UWB1.289 cells, and to knockout BRCA1 in the FEN1-inhibitor resistant OV90 cells, followed by measuring the response of BRCA1-edited clones to FEN1-inhibitor SMD2485. With UWB1.289, I was unable to propagate plasmid-transfected cells, suggesting a possible sensitivity to exogenous DNA. With OV90, I found that the majority of edited BRCA1-alleles produced proteins with small in-frame deletions (∆BRCA1) and that the few null-alleles underwent further mutations to produce ∆BRCA1 upon propagation in culture. I also found that ∆BRCA1-expressing clones were as resistant as the parental OV90 cells to SMD2485. Due to the sensitivity of UWB1.289 cells to transfection and the instability of BRCA1-null alleles in OV90 cells, this study failed to establish the sufficiency of BRCA1-loss in causing FEN1-inhibitor sensitivity. Alternative strategies to express BRCA1-wt in UWB1.289 cells and to overcome the instability of the BRCA1-null alleles in OV90 cells are discussed as future approaches to test the direct causal relationship between BRCA1-loss and FEN1-dependency in ovarian cancer.

Main Content

This item is under embargo until April 9, 2023.